phenotype

APOPTOSIS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about APOPTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

12345Connections

2Hypotheses

0Analyses

50Outgoing

50Incoming

1Experiments

0Debates

Summary

Apoptosis is programmed cell death essential for normal development and tissue homeostasis. In neurodegeneration, aberrant activation of apoptotic pathways contributes to neuronal loss. Key mediators include caspases, Bcl-2 family proteins, cytochrome c, and death receptors. Both intrinsic (mitochondrial) and extrinsic (death receptor) pathways are implicated in diseases like Alzheimer's, Parkinson's, and ALS.

View on Wiki →

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Apoptosis Pathway in Neurodegeneration

mechanism · 3169 words

→

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        APOPTOSIS["APOPTOSIS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| NLRP3["NLRP3"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| MICROGLIA["MICROGLIA"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| NEURON["NEURON"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| APP["APP"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| GFAP["GFAP"]
        BECN1["BECN1"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
        AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
    end
    subgraph Signaling["Signaling"]
        APOPTOSIS["APOPTOSIS"] -.->|"inhibits"| CANCER["CANCER"]
        APOPTOSIS["APOPTOSIS"] -->|"activates"| Lymphoma["Lymphoma"]
        APOPTOSIS["APOPTOSIS"] -->|"activates"| Apoptosis["Apoptosis"]
        MITOPHAGY["MITOPHAGY"] -->|"activates"| APOPTOSIS["APOPTOSIS"]
        AUTOPHAGY["AUTOPHAGY"] -->|"regulates"| APOPTOSIS["APOPTOSIS"]
        AKT["AKT"] -.->|"inhibits"| APOPTOSIS["APOPTOSIS"]
        INFLAMMATION["INFLAMMATION"] -->|"activates"| APOPTOSIS["APOPTOSIS"]
    end
    style APOPTOSIS fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CANCER fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Lymphoma fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style BECN1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style INFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (5311)

Target	Relation	Type	Str
Metastasis	therapeutic_target	pathway	1.00
Drug Resistance	therapeutic_target	pathway	1.00
NEURODEGENERATIVE DISEASES	regulates	gene	1.00
STROKE	therapeutic_target	gene	1.00
Cancer	causes	disease	1.00
Apoptosis	causes	pathway	1.00
PARKINSON	activates	gene	1.00
MTOR	associated_with	gene	1.00
STAT3	activates	gene	1.00
NEURON	activates	gene	1.00
Necroptosis	regulates	pathway	1.00
CANCER	expressed_in	gene	1.00
MITOPHAGY	associated_with	gene	1.00
Stroke	associated_with	disease	1.00
GENES	inhibits	gene	1.00
Autophagy	causes	pathway	1.00
P53	regulates	gene	1.00
Fibrosis	regulates	disease	1.00
DNA	activates	gene	1.00
Angiogenesis	inhibits	pathway	1.00
Dna Repair	regulates	pathway	1.00
GENES	regulates	gene	1.00
Apoptosis	inhibits	pathway	1.00
Mapk	therapeutic_target	pathway	1.00
APP	activates	gene	1.00
INFLAMMATION	inhibits	gene	1.00
Alzheimer	regulates	disease	1.00
Ischemia	regulates	disease	1.00
Cancer	therapeutic_target	disease	1.00
Carcinoma	therapeutic_target	disease	1.00
NEURODEGENERATION	causes	phenotype	1.00
Angiogenesis	activates	pathway	1.00
NRF2	associated_with	gene	1.00
Apoptosis	therapeutic_target	pathway	1.00
Oxidative Stress	therapeutic_target	pathway	1.00
AMPK	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
Apoptosis	interacts_with	pathway	1.00
CANCER	causes	gene	1.00
APP	associated_with	gene	1.00
Inflammasome	activates	pathway	1.00
Cardiac	activates	disease	1.00
GENES	expressed_in	gene	1.00
GFAP	associated_with	gene	1.00
MITOCHONDRIA	activates	gene	1.00
Lipid Metabolism	activates	pathway	1.00
CANCER	inhibits	disease	1.00
Stroke	regulates	disease	1.00
Autophagy	therapeutic_target	pathway	1.00
Cell Cycle	regulates	pathway	1.00

Incoming (7034)

Source	Relation	Type	Str
entities-ferroptosis	involved_in	wiki	0.00
APOPTOSIS	expressed_in	gene	1.00
BCL-2	associated_with	gene	1.00
BECN1	associated_with	gene	1.00
APOPTOSIS	regulates	gene	1.00
BAX	regulates	gene	1.00
BAX	therapeutic_target	gene	1.00
CANCER	therapeutic_target	gene	1.00
Tumor	regulates	disease	1.00
MIRNAS	therapeutic_target	gene	1.00
AUTOPHAGY	activates	gene	1.00
CANCER	activates	gene	1.00
Fibrosis	therapeutic_target	disease	1.00
TP53	therapeutic_target	gene	1.00
UBIQUITIN	regulates	gene	1.00
DNA	activates	gene	1.00
BCL-2	expressed_in	gene	1.00
DNA	therapeutic_target	gene	1.00
Senescence	regulates	disease	1.00
BAX	expressed_in	gene	1.00
MICRORNAS	therapeutic_target	gene	1.00
Lymphoma	regulates	disease	1.00
P53	regulates	gene	1.00
PI3K	therapeutic_target	gene	1.00
APOPTOSIS	activates	gene	1.00
Alzheimer	inhibits	disease	1.00
BCL2	therapeutic_target	gene	1.00
Lymphoma	therapeutic_target	disease	1.00
Parkinson	associated_with	disease	1.00
AMPK	activates	gene	1.00
APOPTOSIS	therapeutic_target	gene	1.00
BCL2	activates	gene	1.00
MTOR	regulates	gene	1.00
Lymphoma	inhibits	disease	1.00
PI3K	inhibits	gene	1.00
Tumor	inhibits	disease	1.00
GENES	regulates	gene	1.00
C-JUN	activates	gene	1.00
BCL-2	inhibits	gene	1.00
JUN	activates	gene	1.00
P53	inhibits	gene	1.00
TNF	activates	gene	1.00
Als	activates	disease	1.00
PI3K	associated_with	gene	1.00
Cancer	therapeutic_target	disease	1.00
BAX	inhibits	gene	1.00
MIRNAS	activates	gene	1.00
TNF	therapeutic_target	gene	1.00
AKT	therapeutic_target	gene	1.00
AUTOPHAGY	therapeutic_target	gene	1.00

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Apoptosis-Senescence Decision Point Intervention	0.649	-	Senescent cell clearance as neurodegener
Colonic Th17/IL-17A Axis → Peripheral Immune Recruitment to	0.640	neurodegeneration	What are the mechanisms by which gut mic

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (1)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
dilncRNA-mediated molecular crowding and phase separation	exploratory		0.900	0.00	cultured cells	proposed	N/A

Related Papers (1)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Metformin and its potential influence on cell fate decision between apoptosis an [PMID:39267853]	["Hajimohammadebrahim-Ketabforoush M", "	Front Oncol	2024	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning APOPTOSIS in their description or question text

No additional research found